Intermediate | CAS No's | API/End Use | Status |
Ethyl 4-(1-methyl-5-nitro-1H-benzo[d] imidazol-2-yl) butanoate | 3543-73-5 | Bendamustine | Lab Scale |
Ethyl4-(5-amino-1-methyl-1H-benzo[d]imidazole -2- yl)butanoate | 3543-73-5 | Bendamustine | lab Scale |
4-(5-amino-1-methyl-1H-benzimidazol-2-yl)-butyric acid isopropyl ester | 1313020-26-6 | Bendamustine | lab Scale |
S-(+)-Methyl-(2-chlorophenyl)[(2-(2-thienyl)amino]acetate hydrochloride | 141109-19-5 | Clopidogrel | Commercial |
3-amino-4-methylamino-benzoic acid-N-(2-pyridyl)-N-(2- ethoxycarbonylethyl)-amide | 212322-56-0 | Dabigatran | Commercial |
N-(4-cynophenyl)-glycine | 42288-26-6 | Dabigatran | Commercial |
Ethyl 3-(2-((4-cyanophenylamino)methyl)-1-methyl-N- (pyridine-2-yl)-1H-benzo[d]imidazole-5- carboxamido)propanoate | 211915-84-3 | Dabigatran | Commercial |
2-(N-BOC)-Aminothiazole-5-carboxylic acid | 302964-02-9 | Dasatinib | Commercial |
2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide | 302964-24-5 | Dasatinib | Under Development |
N-(2-Chloro-6-methylphenyl)-2-[(6-chloro-2-methyl-4-pyrimidinyl)amino]-5-thiazolecarboxamide | 302964-08-5 | Dasatinib | Under Development |
4,6-dichloro-2-methylpyrimidine | 1780-26-3 | Dasatinib | Under Development |